Trial intelligence / Profile preview

Atorvastatin for Monocyte Activation in HIV

NCT01600170Phase 4Completed

Sponsor
University of Pennsylvania
Start
Jan 2013
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in HIV-associated neurocognitive disorder (HAND), sponsored by University of Pennsylvania. Started Jan 2013; status: completed.

02

Drugs

atorvastatin
03

Conditions

HIV-associated neurocognitive disorder (HAND)

Beyond the preview

Go deeper on NCT01600170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01600170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call